9 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... ATS/STS/STR Clinical ... goals of assessing lung ... Predicted very short ... #MPE #Algorithm
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Malignant Pleural Effusion ... (MPE) - Lung POCUS ... #MPE #Lung #POCUS ... #clinical #ultrasound ... #pulmonary
Lung POCUS: Small right anechoic parapneumonic effusion. Note B-lines. Curvilinear probe used. More commonly seen in
Lung POCUS: Small ... parapneumonic effusion ... incidence on prelim reports ... #Lung #POCUS #Pulmonary ... #Ultrasound #Clinical
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Effusion ... #Pleural #Pulmonary
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Plexiform-lesion formation Clinical ... 6 months after PE ... • Ventilation-perfusion ... lung scanning showing ... Thromboendarterectomy #diagnosis #management
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
under-layer ideally long-cuffed ... on exhalation port ... using BVM: Hold mask ... Internet Book of Critical ... Checklist #SARSCoV2 #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
to be in ADHF starts ... importantly, bedside ultrasound ... with presence of pulmonary ... #differential #algorithm ... #management #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
stairs, brisk 4 mph ... event, follow ACC algorithm ... Change in clinical ... unless prior heart/lung ... medical and surgical management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... thickening or effusion ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... MALT Lymphoma • Lung